Good regulatory progress but more needed, China says
This article was originally published in Scrip
Executive Summary
China's State Council has published a white paper outlining the measures the country has taken over the past few years to improve the regulation of pharmaceuticals and other medical products, which concludes that while "remarkable progress" has been made the country "is still facing many difficulties and problems".